Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Basiliximab in Pediatric Renal Transplantation
NCT00228020Phase 3Completed
- Sponsor
- Novartis
- Start
- May 2001
- Primary completion
- Jan 2006
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of basiliximab in kidney transplant rejection, sponsored by Novartis. Started May 2001; status: completed.
02
Drugs
basiliximab
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00228020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00228020.